Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.

Karin Hartmann; Jason Gotlib; Cem Akin; Olivier Hermine; Farrukh T Awan; Elizabeth Hexner; Michael J Mauro; Hans D Menssen; Suman Redhu; Stefanie Knoll; Karl Sotlar; Tracy I George; Hans-Peter Horny; Peter Valent; Andreas Reiter; Hanneke C Kluin-Nelemans

doi:10.1016/j.jaci.2020.03.044

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.

Karin Hartmann
, Jason Gotlib
, Cem Akin
, Olivier Hermine
, Farrukh T Awan
, Elizabeth Hexner
, Michael J Mauro
, Hans D Menssen
, Suman Redhu
, Stefanie Knoll
, Karl Sotlar (Co-author)
, Tracy I George
, Hans-Peter Horny
, Peter Valent
, Andreas Reiter
, Hanneke C Kluin-Nelemans

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

52 Citations (Web of Science)

Original language	English
Pages (from-to)	356-366.e4
Journal	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume	146
Issue number	2
DOIs	https://doi.org/10.1016/j.jaci.2020.03.044
Publication status	Published - 2020

Keywords

RESPONSE CRITERIA
ASSESSMENT SCALE
CANCER-PATIENTS
CLASSIFICATION
EFFICACY
SAFETY
RELIABILITY
PREVALENCE
VALIDATION
ACTIVATION

Access to Document

10.1016/j.jaci.2020.03.044

Cite this

Hartmann, K., Gotlib, J., Akin, C., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Menssen, H. D., Redhu, S., Knoll, S., Sotlar, K., George, T. I., Horny, H.-P., Valent, P., Reiter, A., & Kluin-Nelemans, H. C. (2020). Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 146(2), 356-366.e4. https://doi.org/10.1016/j.jaci.2020.03.044

Hartmann, Karin ; Gotlib, Jason ; Akin, Cem et al. / Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2020 ; Vol. 146, No. 2. pp. 356-366.e4.

@article{fca48eedd17246a7810ac83b9d5c3e93,

title = "Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.",

keywords = "RESPONSE CRITERIA, ASSESSMENT SCALE, CANCER-PATIENTS, CLASSIFICATION, EFFICACY, SAFETY, RELIABILITY, PREVALENCE, VALIDATION, ACTIVATION",

author = "Karin Hartmann and Jason Gotlib and Cem Akin and Olivier Hermine and Awan, \{Farrukh T\} and Elizabeth Hexner and Mauro, \{Michael J\} and Menssen, \{Hans D\} and Suman Redhu and Stefanie Knoll and Karl Sotlar and George, \{Tracy I\} and Hans-Peter Horny and Peter Valent and Andreas Reiter and Kluin-Nelemans, \{Hanneke C\}",

note = "Sotlar: Institute of Pathology, Paracelsus Medical University Salzburg, Austria",

year = "2020",

doi = "10.1016/j.jaci.2020.03.044",

language = "English",

volume = "146",

pages = "356--366.e4",

journal = "JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY ",

issn = "0091-6749",

publisher = "Elsevier ",

number = "2",

}

Hartmann, K, Gotlib, J, Akin, C, Hermine, O, Awan, FT, Hexner, E, Mauro, MJ, Menssen, HD, Redhu, S, Knoll, S, Sotlar, K, George, TI, Horny, H-P, Valent, P, Reiter, A & Kluin-Nelemans, HC 2020, 'Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , vol. 146, no. 2, pp. 356-366.e4. https://doi.org/10.1016/j.jaci.2020.03.044

Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. / Hartmann, Karin; Gotlib, Jason; Akin, Cem et al.
In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , Vol. 146, No. 2, 2020, p. 356-366.e4.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.

AU - Hartmann, Karin

AU - Gotlib, Jason

AU - Akin, Cem

AU - Hermine, Olivier

AU - Awan, Farrukh T

AU - Hexner, Elizabeth

AU - Mauro, Michael J

AU - Menssen, Hans D

AU - Redhu, Suman

AU - Knoll, Stefanie

AU - Sotlar, Karl

AU - George, Tracy I

AU - Horny, Hans-Peter

AU - Valent, Peter

AU - Reiter, Andreas

AU - Kluin-Nelemans, Hanneke C

N1 - Sotlar: Institute of Pathology, Paracelsus Medical University Salzburg, Austria

PY - 2020

Y1 - 2020

KW - RESPONSE CRITERIA

KW - ASSESSMENT SCALE

KW - CANCER-PATIENTS

KW - CLASSIFICATION

KW - EFFICACY

KW - SAFETY

KW - RELIABILITY

KW - PREVALENCE

KW - VALIDATION

KW - ACTIVATION

U2 - 10.1016/j.jaci.2020.03.044

DO - 10.1016/j.jaci.2020.03.044

M3 - Original Article

C2 - 32437738

SN - 0091-6749

VL - 146

SP - 356-366.e4

JO - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

JF - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IS - 2

ER -

Hartmann K, Gotlib J, Akin C, Hermine O, Awan FT, Hexner E et al. Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 2020;146(2):356-366.e4. doi: 10.1016/j.jaci.2020.03.044